The New Brunswick Drug Plans (New Brunswick Prescription Drug Program and New Brunswick Drug Plan) cover certain smoking cessation therapies for individuals enrolled in Plans ADEFGV as outlined below.
Smoking Cessation Therapies
A maximum of 12 weeks of standard therapy will be reimbursed annually without special authorization (SA) for either:
SA Requests for Additional Quantities
Additional reimbursement of either bupropion or varenicline OR Nicotine Replacement Therapy (patches only) for individuals who have a high probability of quitting with prolonged therapy will require Special Authorization using the Request for Additional Smoking Cessation Therapy Form.
All requests for additional therapy will require confirmation that the individual is participating in a form of smoking cessation counselling to be specified.
Refer to the Request for Additional Smoking Cessation Therapy Form for further information on additional quantities of smoking cessation therapies permitted annually.
The Request for Additional Smoking Cessation Therapy Form can be completed by a licensed prescriber, pharmacist, nurse, or a respiratory therapist. A separate patient prescription must be written by a licensed prescriber (physician, nurse practitioner, or pharmacist) for all nicotine replacement and non-nicotine smoking cessation therapies.
- The current dispensing fee and mark-up apply to claims for all smoking cessation products (including Nicotine Replacement Therapies). Please refer to the Dispensing Fees and Drug Cost Reimbursement web page for the applicable amounts.
- The Frequency of Dispensing and Payment Policy applies. The exceptions to this policy (e.g. daily and weekly dispensing) are not permitted for smoking cessation therapies.
- Information to be included in claims is outlined here New Brunswick Drug Plans Claim Submissions
- Claims that do not comply with the policies of the New Brunswick Drug Plans are subject to audit and recovery.